← Leaderboards
Kathleen Colleran
University Of New Mexico
$1,079,678
Attributed
$1,079,678
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $142.4K · FY2005–10$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,079,678 · 18
By mechanism
M01$1,079,678 · 18
Top collaborators
No co-investigators on record.
Most similar at University Of New Mexico
Same institution · by research overlap
- Joseph Anderson$223,763
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantResearch PersonnelResourcesInstitutionSourceFundingComputer Retrieval Of Information On Scientific Projects DatabaseUnited States National Institutes Of HealthClinical ResearchHomocysteineHuman SubjectOxidative StressBiomarkerDisease /Disorder EtiologyAtorvastatinPharmaceutical PreparationsPlasminogen Activator Inhibitor 1InflammationHyperthyroidismHydrochlorothiazideResponseAmlodipineBlood PressureFolate Deficiency
Grant awards (23)
THE PLEIOTROPIC EFFECTS OF ATORVASTATIN WHEN COMBINED WITH$21,156
M01 · FY2010 · RR · contact PI
DECREASED PULMONARY FUNCTION, YET ANOTHER RAMIFICATION OF CHILDHOOD$255
M01 · FY2010 · RR · contact PI
THE PLEIOTROPIC EFFECTS OF ATORVASTATIN WHEN COMBINED WITH$16,516
M01 · FY2009 · RR · contact PI
HEALTH OUTCOMES ASSOCIATED WITH THE INTRODUCTION OF A MULTIDISCIPLINARY$13,083
M01 · FY2008 · RR · contact PI
CARVEDILOL VS METOPOLOL: A COMPARISON OF ENDOTHELIAL FUNCTION$6,784
M01 · FY2008 · RR · contact PI
THE PLEIOTROPIC EFFECTS OF ATORVASTATIN WHEN COMBINED WITH$484
M01 · FY2008 · RR · contact PI
CARVEDILOL VS METOPOLOL: A COMPARISON OF ENDOTHELIAL FUNCTION$63,090
M01 · FY2007 · RR · contact PI
THE PLEIOTROPIC EFFECTS OF ATORVASTATIN WHEN COMBINED WITH$42,995
M01 · FY2007 · RR · contact PI
THE ROLE OF PAI-1 AND ADIPOSE METABOLIC ACTIVITY IN THE CARDIOPROTECTION$5,608
M01 · FY2007 · RR · contact PI
HEALTH OUTCOMES ASSOCIATED WITH THE INTRODUCTION OF A MULTIDISCIPLINARY$5,608
M01 · FY2007 · RR · contact PI
CARVEDILOL VS METOPOLOL: A COMPARISON OF ENDOTHELIAL FUNCTION$100,203
M01 · FY2006 · RR · contact PI
THE ROLE OF PAI-1 AND ADIPOSE METABOLIC ACTIVITY IN THE CARDIOPROTECTION$35,256
M01 · FY2006 · RR · contact PI
THE PLEIOTROPIC EFFECTS OF ATORVASTATIN WHEN COMBINED WITH$5,103
M01 · FY2006 · RR · contact PI
HEALTH OUTCOMES ASSOCIATED WITH THE INTRODUCTION OF A MULTIDISCIPLINARY$1,855
M01 · FY2006 · RR · contact PI
THE ROLE OF PAI-1 AND ADIPOSE METABOLIC ACTIVITY IN THE CARDIOPROTECTION$82,392
M01 · FY2005 · RR
HEALTH OUTCOMES ASSOCIATED WITH THE INTRODUCTION OF A MULTIDISCIPLINARY$38,413
M01 · FY2005 · RR
CARVEDILOL VS METROPOLOL: A COMPARISON OF EFFECTS ON ENDOTHELIAL$3,340
M01 · FY2005 · RR
Health Outcomes of CHD$26,816
M01 · FY2004 · RR
Carvedilol vs. Metropolol: Effects on Endothelial$23,464
M01 · FY2004 · RR
THYROTOXICOSIS MAY BE ASSOCIATED W/ VITAMIN B &FOLATE DEFICIENCIES$282,412
M01 · FY2002 · RR
THYROTOXICOSIS MAY BE ASSOCIATED W/ VITAMIN B &FOLATE DEFICIENCIES$282,412
M01 · FY2001 · RR
THYROTOXICOSIS MAY BE ASSOCIATED W/ VITAMIN B &FOLATE DEFICIENCIES$22,433
M01 · FY2000 · RR
THYROTOXICOSIS MAY BE ASSOCIATED W/ VITAMIN B &FOLATE DEFICIENCIES$0
M01 · FY2000 · RR